A Study of ION251 Administered to Patients With Relapsed/Refractory Multiple Myeloma
Clinical trial NCT04398485 · COMPLETED
Trial details
- NCT number
- NCT04398485
- Sponsor
- Ionis Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-20
- Primary completion
- 2024-09-30
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.